The role of exercise in modifying outcomes for people with multiple sclerosis: a randomized trial

Nancy E Mayo, Mark Bayley, Pierre Duquette, Yves Lapierre, Ross Anderson, Susan Bartlett, Nancy E Mayo, Mark Bayley, Pierre Duquette, Yves Lapierre, Ross Anderson, Susan Bartlett

Abstract

Background: Despite the commonly known benefits of exercise and physical activity evidence shows that persons Multiple Sclerosis (MS) are relatively inactive yet physical activity may be even more important in a population facing functional deterioration. No exercise is effective if it is not done and people with MS face unique barriers to exercise engagement which need to be overcome. We have developed and pilot tested a Multiple Sclerosis Tailored Exercise Program (MSTEP) and it is ready to be tested against general guidelines for superiority and ultimately for its impact on MS relevant outcomes. The primary research question is to what extent does an MS Tailored Exercise Program (MSTEP) result in greater improvements in exercise capacity and related outcomes over a one year period in comparison to a program based on general guidelines for exercise among people with MS who are sedentary and wish to engage in exercise as part of MS self-management.

Methods/design: The proposed study is an assessor-blind, parallel-group, randomized controlled trial (RCT). The duration of the intervention will be one year with follow-up to year two. The targeted outcomes are exercise capacity, functional ambulation, strength, and components of quality of life including frequency and intensity of fatigue symptoms, mood, global physical function, health perception, and objective measures of activity level. Logistic regression will be used to test the main hypothesis related to the superiority of the MSTEP program based on a greater proportion of people making a clinically relevant gain in exercise capacity at 1 year and at 2 years, using an intention-to-treat approach. Sample size will be 240 (120 per group).

Discussion: The MS community is clearly looking for interventions to help alleviate the disabling sequelae of MS and promote health. Exercise is a well-known intervention which has known benefits to all, yet few exercise regularly. For people with MS, the role of exercise in MS management needs to be rigorously assessed to inform people as to how best to use exercise to reduce disability and promote health.

Trial registration: Clinical Trials.gov: NCT01611987.

Figures

Figure 1
Figure 1
The path of participants through the study protocol.

References

    1. Warren S, Warren KG. Prevalence, incidence, and characteristics of multiple sclerosis in Westlock County, Alberta, Canada. Neurology. 1993;43:1760–1763. doi: 10.1212/WNL.43.9.1760.
    1. Warren S, Warren KG. Prevalence of multiple sclerosis in Barrhead county, Alberta, Canada. Can J Neurol Sci. 1992;19:72–75.
    1. Warren S, Warren KG, Svenson LW, Schopflocher DP, Jones A. Geographic and temporal distribution of mortality rates for multiple sclerosis in Canada, 1965–1994. Neuroepidemiology. 2003;22:75–81. doi: 10.1159/000067111.
    1. Warren S, Svenson LW, Warren KG, Metz LM, Patten SB, Schopflocher DP. Incidence of multiple sclerosis among First Nations people in Alberta, Canada. Neuroepidemiology. 2007;29:21–27.
    1. Turner AP, Kivlahan DR, Haselkorn JK. Exercise and quality of life among people with multiple sclerosis: looking beyond physical functioning to mental health and participation in life. Arch Phys Med Rehabil. 2009;90:420–428. doi: 10.1016/j.apmr.2008.09.558.
    1. Multiple Sclerosis Society of Canada. Multiple Sclerosis Society of Canada. Canada: MS Society of Canada; 2009. .
    1. Patwardhan MB, Matchar DB, Samsa GP, McCrory DC, Williams RG, Li TT. Cost of multiple sclerosis by level of disability: a review of literature. Mult Scler. 2005;11:232–239. doi: 10.1191/1352458505ms1137oa.
    1. Stuv O, Oksenberg J. Multiple Sclerosis Overview. GENE Reviews. 2006. pp. 1–10.
    1. Kesselring J, Beer S. Rehabilitation in Multiple Sclerosis. Advances in Clinical Neuroscience and Rehabilitation. 2002;2:6–8.
    1. Kantarci O, Wingerchuk D. Epidemiology and natural history of multiple sclerosis: new insights. Curr Opin Neurol. 2006;19:248–254. doi: 10.1097/01.wco.0000227033.47458.82.
    1. Kantarci OH, Weinshenker BG. Natural history of multiple sclerosis. Neurol Clin. 2005;23:17–38. doi: 10.1016/j.ncl.2004.10.002.
    1. White LJ, Castellano V. Exercise and brain health–implications for multiple sclerosis: Part 1–neuronal growth factors. Sports Med. 2008;38:91–100. doi: 10.2165/00007256-200838020-00001.
    1. White LJ, Castellano V. Exercise and brain health–implications for multiple sclerosis: Part II–immune factors and stress hormones. Sports Med. 2008;38:179–186. doi: 10.2165/00007256-200838030-00001.
    1. Dalgas U, Stenager E, Ingemann-Hansen T. Multiple sclerosis and physical exercise: recommendations for the application of resistance-, endurance- and combined training. Mult Scler. 2008;14:35–53. doi: 10.1177/1352458507079445.
    1. Mayo N. Setting the agenda for multiple sclerosis rehabilitation research. Mult Scler. 2008;14:1154–1156. doi: 10.1177/1352458508096567.
    1. Motl RW, Snook EM, McAuley E, Scott JA, Douglass ML. Correlates of physical activity among individuals with multiple sclerosis. Ann Behav Med. 2006;32:154–161. doi: 10.1207/s15324796abm3202_13.
    1. Motl RW, Snook EM, McAuley E, Gliottoni RC. Symptoms, self-efficacy, and physical activity among individuals with multiple sclerosis. Res Nurs Health. 2006;29:597–606. doi: 10.1002/nur.20161.
    1. American College of Sports Medicine. ACSM's Resource Manual for Guidelines for Exercise Testing and Prescription, 6th edition edn. Baltimore, MD: Lippincott Williams & Wilkins; 2010.
    1. Motl RW, McAuley E, Snook EM, Motl RW, McAuley E, Snook EM. Physical activity and multiple sclerosis: a meta-analysis. Mult Scler. 2005;11:459–463. doi: 10.1191/1352458505ms1188oa.
    1. Rietberg MB, Brooks D, Uitdehaag BM, Kwakkel G. Exercise therapy for multiple sclerosis. Cochrane Database Syst Rev. 2005. CD003980.
    1. Asano M, Dawes D, Arafah A, Moriello C, Mayo N. What does a structured review of the effectiveness of exercise interventions for persons with multiple sclerosis tell us about the challenges of designing trials? Mult Scler. 2009;15:412–421.
    1. Stuifbergen AK. Physical activity and perceived health status in persons with multiple sclerosis. J Neurosci Nurs. 1997;29:238–243. doi: 10.1097/01376517-199708000-00004.
    1. Dalgas U, Stenager E, Jakobsen J, Petersen T, Hansen HJ, Knudsen C. et al.Resistance training improves muscle strength and functional capacity in multiple sclerosis. Neurology. 2009;73:1478–1484. doi: 10.1212/WNL.0b013e3181bf98b4.
    1. Khan F, Pallant JF, Brand C, Kilpatrick TJ. Effectiveness of rehabilitation intervention in persons with multiple sclerosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2008;79:1230–1235. doi: 10.1136/jnnp.2007.133777.
    1. Dettmers C, Sulzmann M, Ruchay-Plossl A, Gutler R, Vieten M. Endurance exercise improves walking distance in MS patients with fatigue. Acta Neurol Scand. 2009;120:251–257. doi: 10.1111/j.1600-0404.2008.01152.x.
    1. Plow MA, Mathiowetz V, Lowe DA. Comparing individualized rehabilitation to a group wellness intervention for persons with multiple sclerosis. Am J Health Promot. 2009;24:23–26. doi: 10.4278/ajhp.071211128.
    1. Collett J, Dawes H, Meaney A, Sackley C, Barker K, Wade D. et al.Exercise for multiple sclerosis: a single-blind randomized trial comparing three exercise intensities. Mult Scler. 2011;17:594–603. doi: 10.1177/1352458510391836.
    1. Castro-Sanchez AM, Mataran-Penarrocha GA, Lara-Palomo I, Saavedra-Hernandez M, Arroyo-Morales M, Moreno-Lorenzo C. Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evid Based Complement Alternat Med. 2012;201(2):473963.
    1. Chang YJ, Hsu MJ, Chen SM, Lin CH, Wong AM. Decreased central fatigue in multiple sclerosis patients after 8 weeks of surface functional electrical stimulation. J Rehabil Res Dev. 2011;48:555–564. doi: 10.1682/JRRD.2010.03.0038.
    1. Hayes HA, Gappmaier E, LaStayo PC. Effects of high-intensity resistance training on strength, mobility, balance, and fatigue in individuals with multiple sclerosis: a randomized controlled trial. J Neurol Phys Ther. 2011;35:2–10. doi: 10.1097/NPT.0b013e31820b5a9d.
    1. Hebert JR, Corboy JR, Manago MM, Schenkman M. Effects of vestibular rehabilitation on multiple sclerosis-related fatigue and upright postural control: a randomized controlled trial. Phys Ther. 2011;91:1166–1183. doi: 10.2522/ptj.20100399.
    1. Rampello A, Franceschini M, Piepoli M, Antenucci R, Lenti G, Olivieri D. et al.Effect of aerobic training on walking capacity and maximal exercise tolerance in patients with multiple sclerosis: a randomized crossover controlled study. Phys Ther. 2007;87:545–555. doi: 10.2522/ptj.20060085.
    1. Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol. 1996;39:432–441. doi: 10.1002/ana.410390405.
    1. De Souza-Teixeira F, Costilla S, Ayan C, Garcia-Lopez D, Gonzalez-Gallego J, De Paz JA. Effects of resistance training in multiple sclerosis. Int J Sports Med. 2009;30:245–250. doi: 10.1055/s-0028-1105944.
    1. Lucio AC, Campos RM, Perissinotto MC, Miyaoka R, Damasceno BP, D'ancona CA. Pelvic floor muscle training in the treatment of lower urinary tract dysfunction in women with multiple sclerosis. Neurourol Urodyn. 2010;29:1410–1413. doi: 10.1002/nau.20941.
    1. McClurg D, Lowe-Strong A, Ashe R. Pelvic floor training for lower urinary tract dysfunction in MS. Nurs Times. 2009;105:45–47.
    1. McClurg D, Ashe RG, Marshall K, Lowe-Strong AS. Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot study. Neurourol Urodyn. 2006;25:337–348. doi: 10.1002/nau.20209.
    1. DeRidder D, Vermeulen C, Ketelaer P, Van PH, Baert L. Pelvic floor rehabilitation in multiple sclerosis. Acta Neurol Belg. 1999;99:61–64.
    1. White LJ, Dressendorfer RH, White LJ, Dressendorfer RH. Exercise and multiple sclerosis. Sports Med. 2004;34:1077–1100. doi: 10.2165/00007256-200434150-00005.
    1. American College of Sports Medicine. Musculoskeltal, Neuromuscular, Neoplastic, Immunologic, and Hematologic Conditions. In: Myers JN, Herbert WG, Humphrey R, editor. ACSM's Resources for Clinical Exercise Physiology. Baltimore, MD: Lippincot Williams & Wilkins; 2002.
    1. Johnston K, Carlye L, Rattray S. MS Active Now: Understanding MS and Exercise. Alberta Division: Multiple Sclerosis Society of Canada; 2008.
    1. American College of Sports Medicine. ACSM's Resources for Clinical Exercise Physiology: Musculoskeltal, Neuromuscular, Neoplastic, Immunologic, and Hematologic Conditions, Second edition edn. Baltimore, MD: Lippincott Williams & Wilkins; 2010.
    1. Canadian Society for Exercise Physiology. Canadian Physical Activity Guidelines for Adults with Multiple Sclerosis. 2013. .
    1. Asano M, Duquette P, Andersen R, Lapierre Y, Mayo NE. Exercise barriers and preferences among women and men with multiple sclerosis. Disabil Rehabil. 2013;35:353–361. doi: 10.3109/09638288.2012.742574.
    1. Zifko UA. Management of fatigue in patients with multiple sclerosis. Drugs. 2004;64
    1. Kuspinar A, Andersen R, Mayo NE. Predicting Exercise Capacity through Sub-Maximal Fitness Testing in Persons with Multiple Sclerosis. Arch Phys Med Rehabil. 2010;91:1410–1417. doi: 10.1016/j.apmr.2010.06.005.
    1. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M. et al.Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292–302. doi: 10.1002/ana.22366.
    1. Varga J, Porszasz J, Boda K, Casaburi R, Somfay A. Supervised high intensity continuous and interval training vs. self-paced training in COPD. Respir Med. 2007;101:2297–2304. doi: 10.1016/j.rmed.2007.06.017.
    1. Tjonna AE, Lee SJ, Rognmo O, Stolen TO, Bye A, Haram PM. et al.Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation. 2008;118:346–354. doi: 10.1161/CIRCULATIONAHA.108.772822.
    1. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med. 1970;2:92–98.
    1. Wade DT. Goal setting in rehabilitation: an overview of what, why and how. Clin Rehabil. 2009;23:291–295. doi: 10.1177/0269215509103551.
    1. Bovend'Eerdt TJ, Botell RE, Wade DT. Writing SMART rehabilitation goals and achieving goal attainment scaling: a practical guide. Clin Rehabil. 2009;23:352–361. doi: 10.1177/0269215508101741.
    1. Knauper B, McCollam A, Rosen-Brown A, Lacaille J, Kelso E, Roseman M. Fruitful plans: adding targeted mental imagery to implementation intentions increases fruit consumption. Psychol Health. 2011;26:601–617. doi: 10.1080/08870441003703218.
    1. Gollwitzer PM. Implementation intentions: Strong effects of simple plans. Am Psychol. 1999;54:493–503.
    1. Schulz KH, Gold SM, Witte J, Bartsch K, Lang UE, Hellweg R. et al.Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and coordinative function in multiple sclerosis. J Neurol Sci. 2004;225:11–18. doi: 10.1016/j.jns.2004.06.009.
    1. Bjarnadottir OH, Konradsdottir AD, Reynisdottir K, Olafsson E. Multiple sclerosis and brief moderate exercise. A randomised study. Mult Scler. 2007;13:776–782. doi: 10.1177/1352458506073780.
    1. Gaesser GA, Brooks GA. Muscular efficiency during steady-rate exercise: effects of speed and work rate. J Appl Physiol. 1975;38:1132–1139.
    1. Woo JS, Derleth C, Stratton JR, Levy WC. The influence of age, gender, and training on exercise efficiency. J Am Coll Cardiol. 2006;47:1049–1057. doi: 10.1016/j.jacc.2005.09.066.
    1. Weller IMR, Thomas SG, Corey PN, Cox MH. Prediction of maximal oxygen uptake from a modified canadian aerobic fitness test. Can J Appl Physiol. 1993;18:175–188. doi: 10.1139/h93-014.
    1. Goldman MD, Marrie RA, Cohen JA. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult Scler. 2008;14:383–390. doi: 10.1177/1352458507082607.
    1. Finch E, Brooks D, Stratford PW, Mayo NE. Physical rehabilitation outcome measures. 2. Hamilton: BC Decker Inc.; 2002.
    1. Van den BM, Dawes H, Wade DT, Newman M, Burridge J, Izadi H. et al.Treadmill training for individuals with multiple sclerosis: a pilot randomised trial. J Neurol Neurosurg Psychiatry. 2006;77:531–533. doi: 10.1136/jnnp.2005.064410.
    1. Salbach NM, Mayo NE, Wood-Dauphinee S, Hanley JA, Richards CL, Cote R. A task-orientated intervention enhances walking distance and speed in the first year post stroke: a randomized controlled trial. Clin Rehabil. 2004;18:509–519. doi: 10.1191/0269215504cr763oa.
    1. Garber CE, Friedman JH. Effects of fatigue on physical activity and function in patients with Parkinson's disease. Neurology. 2003;60:1119–1124. doi: 10.1212/01.WNL.0000055868.06222.AB.
    1. Paltamaa J, Sarasoja T, Wikstrom J, Malkia E. Physical functioning in multiple sclerosis: a population-based study in central Finland. J Rehabil Med. 2006;38:339–345. doi: 10.1080/16501970600731537.
    1. Meads DM, Doward LC, McKenna SP, Fisk J, Twiss J, Eckert B. The development and validation of the Unidimensional Fatigue Impact Scale (U-FIS) Mult Scler. 2009;15:1228–1238. doi: 10.1177/1352458509106714.
    1. Gottschalk M, Kumpfel T, Flachenecker P, Uhr M, Trenkwalder C, Holsboer F. et al.Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Arch Neurol. 2005;62:277–280. doi: 10.1001/archneur.62.2.277.
    1. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ. 1993;2:217–227. doi: 10.1002/hec.4730020305.
    1. Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann Med. 2001;33:350–357. doi: 10.3109/07853890109002089.
    1. Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53–72. doi: 10.1016/0168-8510(96)00822-6.
    1. Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D) Br J Rheumatol. 1997;36:551–559. doi: 10.1093/rheumatology/36.5.551.
    1. Myers C, Wilks D. Comparison of Euroqol EQ-5D and SF-36 in patients with chronic fatigue syndrome. Qual Life Res. 1999;8:9–16.
    1. Dorman P, Slattery J, Farrell B, Dennis M, Sandercock P. Qualitative comparison of the reliability of health status assessments with the EuroQol and SF-36 questionnaires after stroke. United Kingdom Collaborators in the International Stroke Trial. Stroke. 1998;29:63–68. doi: 10.1161/01.STR.29.1.63.
    1. Ruta DA, Garratt AM, Leng M, Russell IT, MacDonald LM. A new approach to the measurement of quality of life. The Patient-Generated Index. Med Care. 1994;32:1109–1126.
    1. Ruta DA, Garratt AM, Russell IT. Patient centred assessment of quality of life for patients with four common conditions. Qual Health Care. 1999;8:22–29. doi: 10.1136/qshc.8.1.22.
    1. Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult Scler. 1999;5:349–354.
    1. Godfrey A, Culhane KM, Lyons GM. Comparison of the performance of the activPAL Professional physical activity logger to a discrete accelerometer-based activity monitor. Med Eng Phys. 2007;29:930–934. doi: 10.1016/j.medengphy.2006.10.001.
    1. Lorig K, Stewart A, Ritter P, Gonzalez V, Laurent D, Lynch J. Outcome Measures for Health Education and other health Care Interventions. Thousand Oaks: SAGE; 1996.
    1. Sechrist KR, Walker SN, Pender NJ. Development and psychometric evaluation of the exercise benefits/barriers scale. Res Nurs Health. 1987;10:357–365. doi: 10.1002/nur.4770100603.
    1. Franckowiak SC, Dobrosielski DA, Reilley SM, Walston JD, Andersen RE. Maximal heart rate prediction in adults that are overweight or obese. J Strength Cond Res. 2011;25:1407–1412. doi: 10.1519/JSC.0b013e3181d682d2.
    1. Larson EB, Burnison DS, Brown WS, Larson EB, Burnison DS, Brown WS. Callosal function in multiple sclerosis: bimanual motor coordination. Cortex. 2002;38:201–214. doi: 10.1016/S0010-9452(08)70650-6.
    1. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41:582–592.
    1. Hayes KC. Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis. Neuropsychiatr Dis Treat. 2011;7:229–239.
    1. Henney HR III, Blight AR. Walking impairment in patients with multiple sclerosis - a new therapeutic approach and clinical potential of dalfampridine extended release tablets. Degenerative Neurological and Neuromuscular Disease. 2012;2:53–64.
    1. Bagiella E. Clinical trials in rehabilitation: single or multiple outcomes? Arch Phys Med Rehabil. 2009;90:S17–S21. doi: 10.1016/j.apmr.2009.08.133.
    1. Mayo NE. In: Medical Uses of Statistics. 3. Bailar JC, Hoaglin DC, editor. Hoboken, New Jersey: A John Wiley & Sons, Inc & The New England Journal of Medicine; 2009. Understanding Analyses of Randomized Trials; pp. 195–237.
    1. Rubin DB. The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials. Stat Med. 2007;26:20–36. doi: 10.1002/sim.2739.
    1. Rosenbaum PR, Rubin DB. Reducing Bias in Observational Studies Using Subclassification on the Propensity Score. J Am Stat Assoc. 1984;79:516–524. doi: 10.1080/01621459.1984.10478078.
    1. Groenwold RH, Hak E, Hoes AW. Quantitative assessment of unobserved confounding is mandatory in nonrandomized intervention studies. J Clin Epidemiol. 2009;62:22–28. doi: 10.1016/j.jclinepi.2008.02.011.
    1. Allison PD. Missing Data. Thousand Oaks, California: Sage Publications, Inc.; 2002.
    1. Little R, Rubin D. Statistical Analysis with Missing Data. 2. John Wiley: New York; 2002.
    1. University of Missouri. MyActivity Pyramid for Adults. 2013. pp. 18–64. .
    1. Weeks DL, Noteboom JT. Using the number needed to treat in clinical practice. Arch Phys Med Rehabil. 2004;85:1729–1731. doi: 10.1016/j.apmr.2004.03.025.
    1. Sox HC, Goodman SN. The methods of comparative effectiveness research. Annu Rev Public Health. 2012;33:425–445. doi: 10.1146/annurev-publhealth-031811-124610.
    1. Mayo NE, Scott S. Evaluating a complex intervention with a single outcome may not be a good idea: an example from a randomised trial of stroke case management. Age Ageing. 2011;40:718–724. doi: 10.1093/ageing/afr061.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner